Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6850
+0.0150 (0.90%)
NASDAQ· Last Trade: Jun 10th, 11:29 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors